British Journal of Oral and Maxillofacial Surgery
Volume 47, Issue 3 , Pages 196-199 , April 2009

[18F]-fluoride positron emission tomography for imaging condylar hyperplasia

  • S. Laverick

      Affiliations

    • Regional Maxillofacial Unit, Ninewells hospital, Dundee, United Kingdom
    • Formerly at Department of Oral and Maxillofacial Surgery, Mount Vernon hospital, Middlesex, United Kingdom
    • Corresponding Author InformationCorresponding author. Ninewells hospital, Dundee, Scotland, DD1 9SY, United Kingdom.
  • ,
  • G. Bounds

      Affiliations

    • Department of Oral and Maxillofacial Surgery, Mount Vernon hospital, Middlesex, United Kingdom
  • ,
  • Wai Lup Wong

      Affiliations

    • Department of Radiology, Paul Strickland Scanner Centre, Mount Vernon hospital, Middlesex, United Kingdom

,Accepted 2 August 2008.

References 

  1. Wolford LM, Mehra P, Reiche-Fischel , Morales-Ryan CA, Garcia-Morales P. Efficacy of high condylectomy for management of condylar hyperplasia. Am J Orthod Dentofacial Orthop. 2002;121:136–151
  2. Araz B, Nitzan DW, Brin I. Condylar hyperplasia: remodelling of facial structures following condylectomy. Report of two cases. Int J Adult Orthodon Orthognath Surg. 1991;6:47–55
  3. Francis MD, Fogelman I. 99mTc diphosphonate uptake mechanism on bone. In:  Fogelman I editors. Bone scanning in clinical practice.. London: Springer Verlag; 1987;p. 7–17
  4. Grynpas MD. Fluoride effects on bone crystals. J Bone Miner Res. 1990;5(Suppl 1):169–175
  5. Ackerhalt RE, Blau M, Bakshi S, Sondei JA. A comparative study of three 99mTc-labeled phosphorus compounds and 18F –fluoride for skeletal imaging. J Nucl Med. 1974;15:1153–1157
  6. Krishnamurthy GT, Thomas PB, Tubis M, Endow JS, Pritchard JH, Blahd WH. Comparison of 99mTc polyphosphate and 18-F. I. kinetics. J Nucl Med. 1974;15:832–836
  7. Blau M, Ganatra R, Bender MA. 18F- fluoride for bone imaging. Semin Nucl Med. 1972;2:31–37
  8. Notes for guidance on the clinical administration of radiopharmaceuticals and the use of sealed radioactive sources. ARSAC March 2006. Health Protection Agency (HPA) Part A Diagnostic procedures adult patients 35–39; Part B diagnostic procedures – PET; 40.

PII: S0266-4356(08)00454-3

doi: 10.1016/j.bjoms.2008.08.001

British Journal of Oral and Maxillofacial Surgery
Volume 47, Issue 3 , Pages 196-199 , April 2009